Bank of Montreal’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-55,117
| Closed | -$8.36K | – | 3954 |
|
|
2022
Q3 | $8.36K | Buy |
55,117
+10,150
| +23% | +$1.54K | ﹤0.01% | 915 |
|
|
2022
Q2 | $6.51K | Buy |
+44,967
| New | +$6.51K | ﹤0.01% | 1068 |
|
|
2022
Q1 | – | Sell |
-10,966
| Closed | -$1.53M | – | 3853 |
|
|
2021
Q4 | $1.53M | Sell |
10,966
-3,492
| -24% | -$486K | ﹤0.01% | 1680 |
|
|
2021
Q3 | $1.91M | Buy |
+14,458
| New | +$1.91M | ﹤0.01% | 1937 |
|
|
2021
Q2 | – | Sell |
-1,392
| Closed | -$98K | – | 5103 |
|
|
2021
Q1 | $98K | Sell |
1,392
-6,071
| -81% | -$427K | ﹤0.01% | 3029 |
|
|
2020
Q4 | $645K | Buy |
7,463
+5,229
| +234% | +$452K | ﹤0.01% | 2173 |
|
|
2020
Q3 | $155K | Sell |
2,234
-1,537
| -41% | -$107K | ﹤0.01% | 2481 |
|
|
2020
Q2 | $286K | Buy |
+3,771
| New | +$286K | ﹤0.01% | 2221 |
|
|
2020
Q1 | – | Sell |
-5,267
| Closed | -$287K | – | 4482 |
|
|
2019
Q4 | $287K | Buy |
5,267
+1,537
| +41% | +$83.8K | ﹤0.01% | 2501 |
|
|
2019
Q3 | $156K | Buy |
3,730
+578
| +18% | +$24.2K | ﹤0.01% | 2605 |
|
|
2019
Q2 | $138K | Buy |
3,152
+2,952
| +1,476% | +$129K | ﹤0.01% | 2711 |
|
|
2019
Q1 | $10K | Sell |
200
-404
| -67% | -$20.2K | ﹤0.01% | 3486 |
|
|
2018
Q4 | $22K | Buy |
604
+207
| +52% | +$7.54K | ﹤0.01% | 3268 |
|
|
2018
Q3 | $15K | Buy |
397
+151
| +61% | +$5.71K | ﹤0.01% | 3494 |
|
|
2018
Q2 | $10K | Buy |
+246
| New | +$10K | ﹤0.01% | 3636 |
|
|
2018
Q1 | – | Sell |
-91
| Closed | -$2K | – | 4096 |
|
|
2017
Q4 | $2K | Sell |
91
-4,091
| -98% | -$89.9K | ﹤0.01% | 3751 |
|
|
2017
Q3 | $156K | Buy |
+4,182
| New | +$156K | ﹤0.01% | 2537 |
|